These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The Guillain-Barré syndrome following dengue fever. Esack A; Teelucksingh S; Singh N West Indian Med J; 1999 Mar; 48(1):36-7. PubMed ID: 10375992 [TBL] [Abstract][Full Text] [Related]
43. Experimental immunology of Guillain-Barré syndrome. Abramsky O; Steiner I Int J Neurol; 1981; 15(3-4):301-13. PubMed ID: 6927600 [No Abstract] [Full Text] [Related]
44. Recent advances in the understanding of the immunological basis of peripheral neuropathies. Larner AJ Br J Clin Pract; 1993; 47(5):262-5. PubMed ID: 8292474 [TBL] [Abstract][Full Text] [Related]
45. [A case of Guillain-Barré syndrome with bulbar palsy and a high titer of anti-GT1a antibody]. Hashiguchi S; Ogasawara N; Yoshino H Rinsho Shinkeigaku; 1997 Apr; 37(4):331-3. PubMed ID: 9248344 [TBL] [Abstract][Full Text] [Related]
46. Acute peripheral neuropathy in adults. Guillain-Barré syndrome and related disorders. Pascuzzi RM; Fleck JD Neurol Clin; 1997 Aug; 15(3):529-47. PubMed ID: 9227951 [TBL] [Abstract][Full Text] [Related]
47. [Anti-ganglioside antibodies and peripheral neuropathies]. Humbel RL; Schmit P Rev Med Liege; 1996 May; 51(5):368-75. PubMed ID: 8992559 [No Abstract] [Full Text] [Related]
49. Recurrence of childhood Guillain-Barré syndrome after a long asymptomatic interval: a case report. Martic V; Lepic T J Clin Neuromuscul Dis; 2007 Sep; 9(1):256-61. PubMed ID: 17989590 [TBL] [Abstract][Full Text] [Related]
53. [History of Guillain-Barré syndrome]. Schott B Rev Neurol (Paris); 1982; 138(12):931-8. PubMed ID: 6763295 [TBL] [Abstract][Full Text] [Related]
54. [The pathogenetic and treatment aspects of the neurological manifestations in lumbar osteochondrosis]. Barsukov SF; Gorban' IV; Ermolenko FM; Dmitrashchenko AA; Okutov VD; Peshkov LE; Susin VM Voen Med Zh; 1998 May; 319(5):46-50. PubMed ID: 9680837 [No Abstract] [Full Text] [Related]
55. the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Cook SD; Dowling PC Ann Neurol; 1981; 9 Suppl():70-9. PubMed ID: 6452856 [TBL] [Abstract][Full Text] [Related]
56. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome. Odaka M; Yuki N; Hirata K J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908 [TBL] [Abstract][Full Text] [Related]
57. [Acute demyelinating motor neuropathy: an atypical form of the Guillain-Barre syndrome?]. Corcia P; Beaume A; Guennoc AM; de Toffol B; Preud'homme JL; Autret A Rev Neurol (Paris); 1999 Sep; 155(8):596-7. PubMed ID: 10486851 [TBL] [Abstract][Full Text] [Related]
58. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins. Bentes C; de Carvalho M; de Sá J; Luís ML Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759 [TBL] [Abstract][Full Text] [Related]
59. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Kieseier BC; Kiefer R; Gold R; Hemmer B; Willison HJ; Hartung HP Muscle Nerve; 2004 Aug; 30(2):131-56. PubMed ID: 15266629 [TBL] [Abstract][Full Text] [Related]
60. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. van Doorn PA; Brand A; Vermeulen M Neurology; 1987 Nov; 37(11):1798-802. PubMed ID: 3670618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]